Hikma Pharmaceuticals (HKMPY) Stock Price, Quote, News & History

Q: What sector and industry does Hikma Pharmaceuticals (HKMPY) operate in?

Hikma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

$42.60

Volume / Avg.

183.00 / 4.37K

Day Range

$42.60 - $42.60

52 Wk Range

39.93 - 59.26

Market Cap

$4.73B

P/E Ratio

12.68

Dividend Yield

3.97%

Exchange

OTC

RSI

Short Interest

Days to Cover

1.17

Recent Hikma Pharmaceuticals PLC News

Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.

Vandana Singh

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and claim the company raised Xyrem's price by over 800%.

Vandana Singh

Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape

The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat various cancers and autoimmune diseases like rheumatoid arthritis, as stated by the National Cancer Institute.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

527.00M

Investing Cash Flow (TTM)

-490.00M

Financing Cash Flow (TTM)

-38.00M

Free Cash Flow (TTM)

228.00M

Capital Expenditure (TTM)

-299.00M

Net Change in Cash (TTM)

-1.00M

Valuation Metrics

Enterprise Value

$5.97B

PE Ratio (TTM)

12.68

PE Ratio (FWD)

9.40

PEG Ratio (TTM)

PS Ratio (TTM)

1.47

PB Ratio (TTM)

1.85

Earnings Yield % (TTM)

7.89%

Earnings Yield % (FWD)

10.64%

EV / EBITDA (TTM)

8.15

Price / EBITDA (TTM)

6.43

Price / Free Cash Flow (TTM)

20.69

Book Value / Share

$22.92

Company Debt

Total Debt

$1.50B

LT Debt

$798.00M

LT Debt Issuance (TTM)

$875.00M

LT Debt Repayment (TTM)

-$602.00M

Total Cash

$236.00M

Debt to Equity

0.61

Issuance of Debt (TTM)

$273.00M

Repayment of Debt (TTM)

-$917.00M

Key Statistics

Open

$42.60

Volume / Avg.

183.00 / 4.37K

Day Range

$42.60 - $42.60

52 Wk Range

39.93 - 59.26

Market Cap

$4.73B

P/E Ratio

12.68

Dividend Yield

3.97%

Exchange

OTC

RSI

Short Interest

Days to Cover

1.17

About

Sector

Health Care

Industry

Pharmaceuticals

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Hikma Pharmaceuticals (HKMPY) stock?

You can purchase shares of Hikma Pharmaceuticals (OTCPK:HKMPY) through any online brokerage.

View our list of the best stock brokerages

Who are Hikma Pharmaceuticals (HKMPY) competitors?

There are no as such competitors for Hikma Pharmaceuticals.

What is the forecast, or price target, for Hikma Pharmaceuticals (HKMPY) stock?

There is no analysis for Hikma Pharmaceuticals to provide a consensus price target.

What is the current price for Hikma Pharmaceuticals (HKMPY)?

The stock price for Hikma Pharmaceuticals (OTCPK: HKMPY) is $42.6 last updated January 23, 2026 at 3:10 PM EST.

Does Hikma Pharmaceuticals (HKMPY) pay a dividend?

There are no upcoming dividends for Hikma Pharmaceuticals.

When is Hikma Pharmaceuticals (OTCPK:HKMPY) reporting earnings?

Hikma Pharmaceuticals does not have any upcoming earnings scheduled.

Is Hikma Pharmaceuticals (HKMPY) going to split?

There is no upcoming split for Hikma Pharmaceuticals.

What sector and industry does Hikma Pharmaceuticals (HKMPY) operate in?

Hikma Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Comments